Train your school staff. Download or order the Anaphylaxis: Know It. See It. Treat It. Training Video.

CLICK HERE

BioRidge Pharma facilitates the certification and fulfillment
of the EpiPen4Schools orders.
The EpiPen4Schools® program, offered by Mylan Specialty, the marketer and distributor of EpiPen® (epinephrine injection) and EpiPen Jr® (epinephrine injection) Auto-Injectors, was developed to help improve access to epinephrine in the event a person experiences a life-threatening allergic reaction (anaphylaxis) in the school setting.
This access is important because epinephrine is the only first-line treatment for anaphylaxis. According to the food allergy guidelines developed by the National Institute of Allergy and Infectious Diseases, if experiencing anaphylaxis, a person should use an epinephrine auto-injector and seek immediate emergency medical care. Carrying an epinephrine auto-injector does not prevent patients from having an anaphylactic reaction; hence, patients must avoid their triggers at all times.
The program offers four FREE EpiPen® or EpiPen Jr® Auto-Injectors to qualifying public and private kindergarten, elementary, middle and high schools in the U.S. Requirements to qualify for this offer include having a valid prescription. The products are available in the form of two EpiPen 2-Pak® cartons, two EpiPen Jr 2-Pak® cartons or one 2-Pak of each kind. Each EpiPen 2-Pak® contains two single auto-injectors, instructions for use and a EpiPen® Trainer, with no drug and no needle, to help patients become familiar with the administration technique.
In the event that the free supply is used to respond to an allergic emergency (anaphylactic event), qualifying schools are eligible to receive a replenishment order of EpiPen® or EpiPen Jr® Auto-Injectors prior to their annual eligibility date at no additional cost.
If you would like to place an order for
free, discounted, or replenishment product
CLICK HERE to start the process
For more information on anaphylaxis or EpiPen® Auto-Injectors, visit EpiPen.com.